WallStreetZenWallStreetZen

NASDAQ: MLAB
Mesa Laboratories Inc Stock

$111.64-1.16 (-1.03%)
Updated May 24, 2024
MLAB Price
$111.64
Fair Value Price
$255.85
Market Cap
$602.19M
52 Week Low
$82.86
52 Week High
$145.46
P/E
656.71x
P/B
1.49x
P/S
2.65x
PEG
0.75x
Dividend Yield
0.57%
Revenue
$212.87M
Earnings
$948.00k
Gross Margin
61%
Operating Margin
2.16%
Profit Margin
0.4%
Debt to Equity
0.84
Operating Cash Flow
$44M
Beta
0.78
Next Earnings
May 31, 2024
Ex-Dividend
May 31, 2024
Next Dividend
Jun 14, 2024

MLAB Overview

Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in the United States, Europe, the Asia Pacific, and internationally. The company's Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. This segment also provides testing and laboratory services primarily to the dental industry. Its Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. This segment's solutions include protein analysis comprising analysis equipment, CDs, kits, and buffers; and peptide synthesizers that enables to automate chemically synthesized peptides that are used in the creation of peptide therapies, biomaterials, cosmetics, and general research. The company's Calibration Solutions segment designs, manufactures, and markets quality control and calibration products to measure or calibrate temperature, pressure, pH, humidity, and other such parameters used for health and safety purposes in the hospital, medical device manufacturing, pharmaceutical manufacturing, and various laboratory and healthcare environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems. Its Clinical Genomics segment develops, manufactures, and sells genetic analysis tools that include MassARRAY system and consumables, including chips, panels, and chemical reagent solutions used by clinical labs to perform genomic clinical testing in several therapeutic areas, such as newborn screenings, pharmacogenetics, and oncology. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.

Zen Score

Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how MLAB scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

MLAB ($111.64) is undervalued by 56.36% relative to our estimate of its Fair Value price of $255.85 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
MLAB ($111.64) is significantly undervalued by 56.36% relative to our estimate of its Fair Value price of $255.85 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
MLAB ($111.64) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 35 more MLAB due diligence checks available for Premium users.

Be the first to know about important MLAB news, forecast changes, insider trades & much more!

MLAB News

Valuation

MLAB fair value

Fair Value of MLAB stock based on Discounted Cash Flow (DCF)
Price
$111.64
Fair Value
$255.85
Undervalued by
56.36%
MLAB ($111.64) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
MLAB ($111.64) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
MLAB ($111.64) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

MLAB price to earnings (PE)

For valuing profitable companies with steady earnings
Company
656.71x
Industry
12.95x
Market
32.03x
MLAB is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
MLAB is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation

MLAB price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.49x
Industry
3.24x
MLAB is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

MLAB price to earnings growth (PEG)

For valuing profitable companies with growth potential
MLAB is good value based... subscribe to Premium to read more.
PEG Value Valuation

MLAB's financial health

Profit margin

Revenue
$53.5M
Net Income
$2.1M
Profit Margin
4%
MLAB's Earnings (EBIT) of $4.60M... subscribe to Premium to read more.
Interest Coverage Financials
MLAB's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$741.8M
Liabilities
$338.8M
Debt to equity
0.84
MLAB's short-term assets ($118.36M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
MLAB's long-term liabilities ($294.63M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
MLAB's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
MLAB's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$11.5M
Investing
-$80.8M
Financing
$60.8M
MLAB's operating cash flow ($43.77M)... subscribe to Premium to read more.
Debt Coverage Financials

MLAB vs Scientific & Technical Instrument Stocks

TickerMarket Cap1d %P/EP/B
MLAB$602.19M-1.02%656.71x1.49x
VPG$439.34M+1.39%18.08x1.34x
FARO$358.38M-1.53%-8.33x1.37x
MVIS$237.66M+3.60%-2.45x2.53x
BKSY$165.92M0.00%-3.05x2.03x

Mesa Laboratories Stock FAQ

What is Mesa Laboratories's quote symbol?

(NASDAQ: MLAB) Mesa Laboratories trades on the NASDAQ under the ticker symbol MLAB. Mesa Laboratories stock quotes can also be displayed as NASDAQ: MLAB.

If you're new to stock investing, here's how to buy Mesa Laboratories stock.

What is the 52 week high and low for Mesa Laboratories (NASDAQ: MLAB)?

(NASDAQ: MLAB) Mesa Laboratories's 52-week high was $145.46, and its 52-week low was $82.86. It is currently -23.25% from its 52-week high and 34.73% from its 52-week low.

How much is Mesa Laboratories stock worth today?

(NASDAQ: MLAB) Mesa Laboratories currently has 5,394,051 outstanding shares. With Mesa Laboratories stock trading at $111.64 per share, the total value of Mesa Laboratories stock (market capitalization) is $602.19M.

Mesa Laboratories stock was originally listed at a price of $6.75 in Dec 31, 1997. If you had invested in Mesa Laboratories stock at $6.75, your return over the last 26 years would have been 1,553.93%, for an annualized return of 11.4% (not including any dividends or dividend reinvestments).

How much is Mesa Laboratories's stock price per share?

(NASDAQ: MLAB) Mesa Laboratories stock price per share is $111.64 today (as of May 24, 2024).

What is Mesa Laboratories's Market Cap?

(NASDAQ: MLAB) Mesa Laboratories's market cap is $602.19M, as of May 25, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Mesa Laboratories's market cap is calculated by multiplying MLAB's current stock price of $111.64 by MLAB's total outstanding shares of 5,394,051.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.